CN102258363B - 代谢热参数测量设备和方法 - Google Patents
代谢热参数测量设备和方法 Download PDFInfo
- Publication number
- CN102258363B CN102258363B CN 201110098409 CN201110098409A CN102258363B CN 102258363 B CN102258363 B CN 102258363B CN 201110098409 CN201110098409 CN 201110098409 CN 201110098409 A CN201110098409 A CN 201110098409A CN 102258363 B CN102258363 B CN 102258363B
- Authority
- CN
- China
- Prior art keywords
- parameter
- temperature
- probe
- heat
- metabolic heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002503 metabolic effect Effects 0.000 title claims abstract description 185
- 238000000034 method Methods 0.000 title claims abstract description 55
- 210000004369 blood Anatomy 0.000 claims abstract description 195
- 239000008280 blood Substances 0.000 claims abstract description 195
- 239000000523 sample Substances 0.000 claims abstract description 162
- 238000001514 detection method Methods 0.000 claims abstract description 62
- 230000000694 effects Effects 0.000 claims abstract description 55
- 235000000346 sugar Nutrition 0.000 claims abstract description 44
- 230000001575 pathological effect Effects 0.000 claims abstract description 27
- 210000000214 mouth Anatomy 0.000 claims abstract description 26
- 230000036760 body temperature Effects 0.000 claims description 132
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 130
- 239000008103 glucose Substances 0.000 claims description 130
- 238000007689 inspection Methods 0.000 claims description 77
- 230000033764 rhythmic process Effects 0.000 claims description 73
- 238000005259 measurement Methods 0.000 claims description 46
- 239000000463 material Substances 0.000 claims description 28
- 230000035479 physiological effects, processes and functions Effects 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 9
- 230000001681 protective effect Effects 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 230000005540 biological transmission Effects 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 230000002093 peripheral effect Effects 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 239000010453 quartz Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000007405 data analysis Methods 0.000 claims description 3
- 230000007613 environmental effect Effects 0.000 abstract description 9
- 230000036757 core body temperature Effects 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 3
- 230000002354 daily effect Effects 0.000 description 35
- 235000001727 glucose Nutrition 0.000 description 33
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 29
- 229910052760 oxygen Inorganic materials 0.000 description 29
- 239000001301 oxygen Substances 0.000 description 29
- 235000012054 meals Nutrition 0.000 description 27
- 230000037323 metabolic rate Effects 0.000 description 26
- 210000002381 plasma Anatomy 0.000 description 25
- 238000012360 testing method Methods 0.000 description 22
- 230000036541 health Effects 0.000 description 16
- 210000000959 ear middle Anatomy 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 13
- 230000008859 change Effects 0.000 description 13
- 150000002304 glucoses Chemical class 0.000 description 12
- 230000005802 health problem Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 230000005906 menstruation Effects 0.000 description 9
- 238000012937 correction Methods 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 206010020850 Hyperthyroidism Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000003340 mental effect Effects 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000000630 rising effect Effects 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 208000032839 leukemia Diseases 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000027758 ovulation cycle Effects 0.000 description 4
- 230000036284 oxygen consumption Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 3
- 208000014311 Cushing syndrome Diseases 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 206010062767 Hypophysitis Diseases 0.000 description 3
- 208000008601 Polycythemia Diseases 0.000 description 3
- 210000004404 adrenal cortex Anatomy 0.000 description 3
- 238000010241 blood sampling Methods 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 208000007451 chronic bronchitis Diseases 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 208000013219 diaphoresis Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- -1 pottery Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- 206010018404 Glucagonoma Diseases 0.000 description 2
- 208000037171 Hypercorticoidism Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 229940121792 Thiazide diuretic Drugs 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 201000005255 adrenal gland hyperfunction Diseases 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000027288 circadian rhythm Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 208000004104 gestational diabetes Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 201000008980 hyperinsulinism Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 206010022498 insulinoma Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 229940127234 oral contraceptive Drugs 0.000 description 2
- 239000003539 oral contraceptive agent Substances 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 208000021255 pancreatic insulinoma Diseases 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000003451 thiazide diuretic agent Substances 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 208000026872 Addison Disease Diseases 0.000 description 1
- 208000000819 Adrenocortical Hyperfunction Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000003606 Congenital Rubella Syndrome Diseases 0.000 description 1
- 206010010619 Congenital rubella infection Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 238000008458 Glucose Oxidase Reagent Methods 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020564 Hyperadrenocorticism Diseases 0.000 description 1
- 206010020674 Hypermetabolism Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021067 Hypopituitarism Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 108010078049 Interferon alpha-2 Proteins 0.000 description 1
- 208000018526 Narcotic-Related disease Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040952 Skin warm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000007357 hyperpituitarism Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000005040 opiate dependence Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004895 regional blood flow Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Abstract
Description
年龄 | 11-15 | 16-17 | 18-19 | 20-30 | 31-40 | 41-50 | 51以上 |
男性 | 46.7 | 46.2 | 39.7 | 37.7 | 37.9 | 35.8 | 35.6 |
女性 | 41.2 | 43.4 | 36.8 | 35.0 | 35.1 | 34.0 | 33.1 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110098409 CN102258363B (zh) | 2011-04-19 | 2011-04-19 | 代谢热参数测量设备和方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110098409 CN102258363B (zh) | 2011-04-19 | 2011-04-19 | 代谢热参数测量设备和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102258363A CN102258363A (zh) | 2011-11-30 |
CN102258363B true CN102258363B (zh) | 2013-03-06 |
Family
ID=45005351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110098409 Active CN102258363B (zh) | 2011-04-19 | 2011-04-19 | 代谢热参数测量设备和方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102258363B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103948375A (zh) * | 2014-05-26 | 2014-07-30 | 黄玉新 | 一种动态的体温监控系统 |
CN104523244B (zh) * | 2015-01-04 | 2017-01-18 | 镇江博联电子科技有限公司 | 基于人体新陈代谢的可穿戴式电子设备及控制方法 |
KR20170022804A (ko) * | 2015-08-21 | 2017-03-02 | 삼성전자주식회사 | 헬스 케어 장치 및 그 동작 방법 |
CN105243260A (zh) * | 2015-09-08 | 2016-01-13 | 深圳市双平泰科技有限公司 | 一种体征数据校正方法及其装置 |
CN105361892A (zh) * | 2015-12-17 | 2016-03-02 | 无锡桑尼安科技有限公司 | 基于人种检测的人员生理状态识别平台 |
CN105361893A (zh) * | 2015-12-17 | 2016-03-02 | 无锡桑尼安科技有限公司 | 一种生理状态识别方法 |
CN106137142A (zh) * | 2016-08-01 | 2016-11-23 | 东莞市嵘丰医疗器械有限公司 | 一种自调节初始温度的耳温枪及其温控方法 |
CN106344038A (zh) * | 2016-08-25 | 2017-01-25 | 何宗彦 | 无创血糖测量系统 |
CN106798545B (zh) * | 2017-03-03 | 2019-10-01 | 董云鹏 | 体温监测系统 |
CN107802255B (zh) * | 2017-11-30 | 2021-01-29 | 杭州电子科技大学 | 一种基于代谢法的血糖数据处理方法及装置 |
TWI678630B (zh) * | 2018-01-16 | 2019-12-01 | 中央研究院 | 非侵入式估測hba1c與血糖值之系統與方法 |
CN108903912A (zh) * | 2018-05-25 | 2018-11-30 | 重庆大学 | 一种幼儿健康状态监测装置及方法 |
CN109727667B (zh) * | 2019-02-27 | 2022-05-31 | 中国人民解放军第四军医大学 | 基于餐后深部体温时间变异性分析的代谢状态评价系统 |
CN109932503B (zh) * | 2019-03-25 | 2020-02-18 | 江苏精策医疗科技有限公司 | 基于肌体产热-散热模型的模拟实验及无创血糖检测方法 |
CN110246589A (zh) * | 2019-05-07 | 2019-09-17 | 深圳市谷德科技有限公司 | 一种基于人体个体差异的体温校正方法及装置 |
CN111053540B (zh) * | 2019-12-23 | 2021-06-29 | 浙江大学 | 一种基于机器学习的crrt上机病人体温校正系统 |
CN113349770A (zh) * | 2021-07-20 | 2021-09-07 | 深圳市微克科技有限公司 | 一种可穿戴光学检测血糖变化趋势 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1548004A (zh) * | 2003-05-07 | 2004-11-24 | ������������ʽ���� | 血糖水平测定设备 |
CN101188968A (zh) * | 2005-03-09 | 2008-05-28 | 拉米尔·法里托维奇·穆辛 | 微量热学测定组织局部代谢率、细胞间质水含量、血液生化成分的浓度和心血管系统张力的方法和装置 |
CN101194838A (zh) * | 2007-12-25 | 2008-06-11 | 何宗彦 | 无创血糖检测仪 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1522254A1 (en) * | 2003-10-08 | 2005-04-13 | Hitachi, Ltd. | Blood sugar level measuring method and apparatus |
-
2011
- 2011-04-19 CN CN 201110098409 patent/CN102258363B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1548004A (zh) * | 2003-05-07 | 2004-11-24 | ������������ʽ���� | 血糖水平测定设备 |
CN101188968A (zh) * | 2005-03-09 | 2008-05-28 | 拉米尔·法里托维奇·穆辛 | 微量热学测定组织局部代谢率、细胞间质水含量、血液生化成分的浓度和心血管系统张力的方法和装置 |
CN101194838A (zh) * | 2007-12-25 | 2008-06-11 | 何宗彦 | 无创血糖检测仪 |
Also Published As
Publication number | Publication date |
---|---|
CN102258363A (zh) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102258363B (zh) | 代谢热参数测量设备和方法 | |
US8676284B2 (en) | Method for non-invasive blood glucose monitoring | |
US20190274551A1 (en) | Core body temperature system | |
Hasselberg et al. | The validity, reliability, and utility of the iButton® for measurement of body temperature circadian rhythms in sleep/wake research | |
US20140142396A1 (en) | Health Measurement Systems | |
KR101421395B1 (ko) | 핸드헬드 의료 디바이스를 위한 전력 관리 | |
EP2005131B1 (en) | Improved digital thermometer | |
Rotello et al. | Comparison of infrared ear thermometer derived and equilibrated rectal temperatures in estimating pulmonary artery temperatures | |
CN101194838B (zh) | 无创血糖检测仪 | |
Lu et al. | A systematic review of body temperature variations in older people | |
US10060802B1 (en) | Intelligent digital thermometer | |
JP2016508755A (ja) | カロリーエネルギー摂取量及び/又は主要栄養素組成を推定するためのシステム及び装置 | |
KR20170022804A (ko) | 헬스 케어 장치 및 그 동작 방법 | |
Kingma et al. | Exploring internal body heat balance to understand thermal sensation | |
Daanen | Infrared tympanic temperature and ear canal morphology | |
JP2006280762A (ja) | ライフコンディションレコーダー装置および身体情報処理システム | |
BR112019016720A2 (pt) | sistema para determinar uma janela fértil de uma mulher, método para determinar uma janela fértil de uma mulher, e programa de computador | |
Lawley et al. | Prolonged (9 h) poikilocapnic hypoxia (12% O2) augments cutaneous thermal hyperaemia in healthy humans | |
Roy et al. | Temporal artery temperature measurements in healthy infants, children, and adolescents | |
CN109932503B (zh) | 基于肌体产热-散热模型的模拟实验及无创血糖检测方法 | |
CN110742591A (zh) | 肚脐测量肠道核温的无创测量方法和设备 | |
Zsuzsanna Balla et al. | Evaluation of commercial, wireless dermal thermometers for surrogate measurements of core temperature | |
US20210177313A1 (en) | Continuous health monitoring system | |
JP3590049B1 (ja) | 血糖値測定装置 | |
Sund-Levander et al. | What is the evidence base for the assessment and evaluation of body temperature |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160214 Address after: 101111 Beijing City, Daxing District branch of Beijing economic and Technological Development Zone, fourteen Street No. 99 building 33 room 508 building B Patentee after: Beijing Galaxy boat Technology Co., Ltd. Address before: 100021 Beijing city Chaoyang District Xiaoyun Road No. 32 Patentee before: He Zongyan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171227 Address after: No. 225300 Jiangsu city of Taizhou province (east side of City Avenue, south medicine medicine City Avenue Road Building 1613, room 1615) C1 Patentee after: Jiangsu sugar three medical technology Co Ltd Address before: 101111 Beijing City, Daxing District branch of Beijing economic and Technological Development Zone, fourteen Street No. 99 building 33 room 508 building B Patentee before: Beijing Galaxy boat Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180713 Address after: 100176 room 33, block B, 99 Chuang fourteen street, Beijing economic and Technological Development Zone, 508. Patentee after: Beijing Galaxy boat Technology Co., Ltd. Address before: 225300 C1, building 1613 and 1615, No. 1, Yao Cheng Road, Jiangsu (Taizhou Road, south side of the city road). Patentee before: Jiangsu sugar three medical technology Co Ltd |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180917 Address after: 213159 Jiangsu Changzhou West Taihu science and technology industry director Yang Road 9 Patentee after: Jiangsu Jing CE Medical Technology Co., Ltd. Address before: 100176 room 33, block B, 99 Chuang fourteen street, Beijing economic and Technological Development Zone, 508. Patentee before: Beijing Galaxy boat Technology Co., Ltd. |